Reproductive health of women with iodine deficiency disorders and antithyroid autoantibodies living in the iodine-deficient region

Aim . To assess the prevalence of gynecological diseases and thyroid status in women with iodine deficiency disorders and antithyroid autoantibodies living in the iodine-deficient region. Materials and Methods . A prospective, controlled, multicenter study involved 99 women of reproductive age residing in the territories of moderate to severe iodine deficiency. The study population was divided into three groups: 1) women with iodine deficiency disorders and antithyroid autoantibodies but without thyroid dysfunction (n = 22); 2) women with iodine deficiency disorders but without antithyroid autoantibodies (n = 35); 3) women without iodine deficiency disorders and antithyroid autoantibodies (n = 34). We then collected clinicopathological data, evaluated gynecological status was evaluated, and measured serum levels of thyroid-stimulating hormone, triiodothyronine (T3), thyroxine (T4), thyroglobulin, antibodies to thyroid peroxidase, and antibodies to thyroglobulin. Results. In total, 62.6 % women were diagnosed with iodine deficiency disorders, and 38.6 % had concomitant thyroid autoantibodies. Women with antithyroid autoantibodies frequently reported fatigue, memory impairment, and had a higher tendency toward overweight and obesity. The majority of women with iodine deficiency disorders and antithyroid autoantibodies (13; 59.1 %) had body mass index > 25.0 kg/m² compared with 12 (34.3 %) women with iodine deficiency disorders but without such autoantibodies (OR = 2.77; 95 % CI [0.92–8.32], p = 0.067). The prevalence of iron-deficiency anemia or latent iron deficiency among women with iodine deficiency disorders and antithyroid autoantibodies was associated with a 3.6-fold higher risk of complications as compared to women with iodine deficiency disorders but without such autoantibodies (OR = 3.63; 95 % CI [1.17–11.22], p = 0.023). Secondary infertility was more common in women with iodine deficiency disorders but without antithyroid autoantibodies (16; 45.7 %, OR = 6.33; 95 % CI [1.59–25.22], p = 0.010). Women with iodine deficiency disorders and antithyroid autoantibodies had a higher frequency of cesarean section due to complicated pregnancy and labor (8; 44.4 %, p = 0.001). Conclusion . Women of reproductive age living in iodinedeficient regions require a multidisciplinary approach, including assessment of thyroid function, detection of latent iron deficiency, preconception counseling, and pregnancy management within a high-risk group for obstetric and perinatal complications.

Authors

Institutions

Publication Details

Journal
Fundamental and Clinical Medicine
Published
2025-09-29
DOI
https://doi.org/10.23946/2500-0764-2025-10-3-36-46
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reproductive health of women with iodine deficiency disorders and antithyroid autoantibodies living in the iodine-deficient region

Yu.A. Dudareva, Larisa V. Antoshkina, Елена Ивановна Пономарева, A. O. Safonova et al.
Fundamental and Clinical Medicine
Thyroid Disorders and Treatments
article

Reproductive health of women with iodine deficiency disorders and antithyroid autoantibodies living in the iodine-deficient region

Yu.A. Dudareva, Larisa V. Antoshkina, Елена Ивановна Пономарева, A. O. Safonova, T. V. Funkner
article en

Abstract

Aim . To assess the prevalence of gynecological diseases and thyroid status in women with iodine deficiency disorders and antithyroid autoantibodies living in the iodine-deficient region. Materials and Methods . A prospective, controlled, multicenter study involved 99 women of reproductive age residing in the territories of moderate to severe iodine deficiency. The study population was divided into three groups: 1) women with iodine deficiency disorders and antithyroid autoantibodies but without thyroid dysfunction (n = 22); 2) women with iodine deficiency disorders but without antithyroid autoantibodies (n = 35); 3) women without iodine deficiency disorders and antithyroid autoantibodies (n = 34). We then collected clinicopathological data, evaluated gynecological status was evaluated, and measured serum levels of thyroid-stimulating hormone, triiodothyronine (T3), thyroxine (T4), thyroglobulin, antibodies to thyroid peroxidase, and antibodies to thyroglobulin. Results. In total, 62.6 % women were diagnosed with iodine deficiency disorders, and 38.6 % had concomitant thyroid autoantibodies. Women with antithyroid autoantibodies frequently reported fatigue, memory impairment, and had a higher tendency toward overweight and obesity. The majority of women with iodine deficiency disorders and antithyroid autoantibodies (13; 59.1 %) had body mass index > 25.0 kg/m² compared with 12 (34.3 %) women with iodine deficiency disorders but without such autoantibodies (OR = 2.77; 95 % CI [0.92–8.32], p = 0.067). The prevalence of iron-deficiency anemia or latent iron deficiency among women with iodine deficiency disorders and antithyroid autoantibodies was associated with a 3.6-fold higher risk of complications as compared to women with iodine deficiency disorders but without such autoantibodies (OR = 3.63; 95 % CI [1.17–11.22], p = 0.023). Secondary infertility was more common in women with iodine deficiency disorders but without antithyroid autoantibodies (16; 45.7 %, OR = 6.33; 95 % CI [1.59–25.22], p = 0.010). Women with iodine deficiency disorders and antithyroid autoantibodies had a higher frequency of cesarean section due to complicated pregnancy and labor (8; 44.4 %, p = 0.001). Conclusion . Women of reproductive age living in iodinedeficient regions require a multidisciplinary approach, including assessment of thyroid function, detection of latent iron deficiency, preconception counseling, and pregnancy management within a high-risk group for obstetric and perinatal complications.

Fundamental and Clinical MedicineVol. 10(3)
Altai State Medical University (RU)
Openalex Percentile: Top 64%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.